Search Results Search Sort by RelevanceMost Recent Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019; 21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019; 21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019; 21(7):E600-602. doi: 10.1001/amajethics.2019.600. Case and Commentary May 2020 When a Patient Regrets Having Undergone a Carefully and Jointly Considered Treatment Plan, How Should Her Physician Respond? Luke V. Selby, MD, MS, Christopher T. Aquina, MD, MPH, and Timothy M. Pawlik, MD, PhD, MPH, MTS Whether a patient’s decisional regret constitutes a failure of shared decision making can depend on how a decision was made. AMA J Ethics. 2020; 22(5):E352-357. doi: 10.1001/amajethics.2020.352. Case and Commentary May 2020 Sliding-Scale Shared Decision Making for Patients With Reduced Capacity Tim Lahey, MD, MMSc and Glyn Elwyn, MD, PhD, MSc Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity. AMA J Ethics. 2020; 22(5):E358-364. doi: 10.1001/amajethics.2020.358. Art of Medicine Jun 2020 On Seeing and Being Seen in Dementia Care Kathryn Hominick, MSW There’s similarity between processes used by an artist to see the entirety of a scene and those used by a clinician to assess a patient. AMA J Ethics. 2020; 22(6):E550-556. doi: 10.1001/amajethics.2020.550. Health Law Mar 2020 Which Legal Approaches Help Limit Harms to Patients From Clinicians’ Conscience-Based Refusals? Rachel Kogan, JD, Katherine L. Kraschel, JD, and Claudia E. Haupt, PhD, JSD When a clinician refuses to do a procedure consistent with standard of care for a patient, legal resources can be helpful. AMA J Ethics. 2020; 22(3):E209-216. doi: 10.1001/amajethics.2020.209. Medicine and Society Mar 2020 How Should We Judge Whether and When Mission Statements Are Ethically Deployed? Kellie E. Schueler and Debra B. Stulberg, MD Mission statements offer limited benefit when patients do not have meaningful choices about where to seek care and can be misused. AMA J Ethics. 2020; 22(3):E239-247. doi: 10.1001/amajethics.2020.239. Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016; 18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019; 21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019; 21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019; 21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Case and Commentary May 2020 When a Patient Regrets Having Undergone a Carefully and Jointly Considered Treatment Plan, How Should Her Physician Respond? Luke V. Selby, MD, MS, Christopher T. Aquina, MD, MPH, and Timothy M. Pawlik, MD, PhD, MPH, MTS Whether a patient’s decisional regret constitutes a failure of shared decision making can depend on how a decision was made. AMA J Ethics. 2020; 22(5):E352-357. doi: 10.1001/amajethics.2020.352.
Case and Commentary May 2020 Sliding-Scale Shared Decision Making for Patients With Reduced Capacity Tim Lahey, MD, MMSc and Glyn Elwyn, MD, PhD, MSc Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity. AMA J Ethics. 2020; 22(5):E358-364. doi: 10.1001/amajethics.2020.358.
Art of Medicine Jun 2020 On Seeing and Being Seen in Dementia Care Kathryn Hominick, MSW There’s similarity between processes used by an artist to see the entirety of a scene and those used by a clinician to assess a patient. AMA J Ethics. 2020; 22(6):E550-556. doi: 10.1001/amajethics.2020.550.
Health Law Mar 2020 Which Legal Approaches Help Limit Harms to Patients From Clinicians’ Conscience-Based Refusals? Rachel Kogan, JD, Katherine L. Kraschel, JD, and Claudia E. Haupt, PhD, JSD When a clinician refuses to do a procedure consistent with standard of care for a patient, legal resources can be helpful. AMA J Ethics. 2020; 22(3):E209-216. doi: 10.1001/amajethics.2020.209.
Medicine and Society Mar 2020 How Should We Judge Whether and When Mission Statements Are Ethically Deployed? Kellie E. Schueler and Debra B. Stulberg, MD Mission statements offer limited benefit when patients do not have meaningful choices about where to seek care and can be misused. AMA J Ethics. 2020; 22(3):E239-247. doi: 10.1001/amajethics.2020.239.
Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016; 18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602.